The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Randomized study to investigate FOLFOXIRI plus either bevacizumab or cetuximab as first-line treatment of BRAF V600E-mutant mCRC: The phase-II FIRE-4.5 study (AIO KRK-0116).
 
Sebastian Stintzing
Honoraria - Amgen; Bayer; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; SERVIER; Taiho Pharmaceutical; Takeda
Consulting or Advisory Role - Amgen; Bayer; Boehringer Ingelheim; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; Sanofi; Sanofi; SERVIER; Takeda
Research Funding - Merck Serono (Inst); Pierre Fabre (Inst); Roche Molecular Diagnostics (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Lilly; Merck KGaA; Pierre Fabre; Roche; Sanofi; Sirtex Medical; Takeda
 
Kathrin Heinrich
Honoraria - Roche Pharma AG
Travel, Accommodations, Expenses - Amgen; Celgene; Lilly
 
David Tougeron
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck Serono; MSD; Sanofi
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Sanofi
 
Dominik Paul Modest
Honoraria - Amgen; Bristol-Myers Squibb; Merck Serono; Merck Sharp & Dohme; Pfizer; Roche; Servier; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Merck Serono; Merck Sharp & Dohme; Roche; SERVIER
Research Funding - Amgen (Inst); Merck (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Bristol-Myers Squibb; Merck Serono; Roche; SERVIER
 
Ingo Schwaner
Honoraria - Abbvie; Janssen; Novartis; Roche; SERVIER
Consulting or Advisory Role - Abbvie; Janssen; Novartis; Roche
Travel, Accommodations, Expenses - Abbvie; Janssen; Novartis
 
Jan Euker
No Relationships to Disclose
 
Rudolf Pihusch
No Relationships to Disclose
 
Martina Stauch
No Relationships to Disclose
 
Florian Kaiser
No Relationships to Disclose
 
Christoph Kahl
No Relationships to Disclose
 
Meinolf Karthaus
No Relationships to Disclose
 
Christian Mueller
No Relationships to Disclose
 
Christof Burkart
No Relationships to Disclose
 
Anke C. Reinacher-Schick
Honoraria - Amgen; AstraZeneca; Aurikamed; Bristol-Myers Squibb; Celgene; iomedico; Lilly; MCI Group; med publico; Merck Serono; MSD; Pfizer; promedicis; Roche; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bristol-Myers Squibb; Celgene; Merck Serono; MSD; Onkowissen; Pfizer; Pierre Fabre; Roche; SERVIER
Research Funding - AIO-Studien (Inst); Alexion Pharmaceuticals (Inst); Amgen (Inst); AstraZeneca (Inst); Celgene (Inst); Georgius Agricola Stiftung Ruhr (Inst); Ipsen (Inst); Lilly (Inst); Ludwig Maximilian University of Munich (Inst); MOLOGEN (Inst); Pharma Consulting Group AB (Inst); PPD Global (Inst); Rafael Pharmaceuticals (Inst); Roche (Inst); Servier (Inst); Syneed Medidata (Inst); University of Cologne (Inst); University of Erlangen-Nuremberg (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Ipsen; MCI Group; Merck Serono; MSD; Onkowissen; Pierre Fabre; Roche; Servier
 
Stefan Kasper
Honoraria - Amgen; Amgen; AstraZeneca; Bristol-Myers Squibb; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi/Aventis; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; AstraZeneca; Bristol-Myers Squibb; Janssen-Cilag; Lilly; Merck Serono; MSD Oncology; Roche; Sanofi; SERVIER
Research Funding - Bristol-Myers Squibb; Celgene; Lilly; Merck Serono; Roche/Genentech; SERVIER
Travel, Accommodations, Expenses - Amgen; Lilly; Merck Serono; Roche; Sanofi
Other Relationship - Amgen; Bristol-Myers Squibb; Lilly; Merck Serono; Roche; Sanofi
 
Ludwig Fischer von Weikersthal
No Relationships to Disclose
 
Beate Krammer-Steiner
No Relationships to Disclose
 
Gerald W. Prager
No Relationships to Disclose
 
Julien Taieb
Consulting or Advisory Role - Amgen; Celgene; Lilly; Merck KGaA; MSD; Pierre Fabre; Roche; SERVIER; Sirtex Medical
Speakers' Bureau - Amgen; Lilly; Merck; MSD; Pierre Fabre; Roche/Genentech; Sanofi; SERVIER
 
Volker Heinemann
Honoraria - Amgen; Baxalta; Boehringer Ingelheim; Celgene; Lilly; Merck; Roche; Sanofi; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Consulting or Advisory Role - Amgen; Baxalta; Boehringer Ingelheim; Bristol-Myers Squibb; Celgene; Halozyme; Merck; MSD; MSD Oncology; Roche; Sanofi; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); Merck (Inst); Roche (Inst); Servier (Inst); Shire (Inst); Sirtex Medical (Inst)
Travel, Accommodations, Expenses - Amgen; Bristol-Myers Squibb; Merck; MSD; Roche; SERVIER; Shire; Sirtex Medical